The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 160, 38-47
Abstract
No abstract availableKeywords
Funding Information
- Chow Sin Lan Charity Fund Limited
- Chan Yin Chuen Memorial Charitable Foundation
- Hong Kong Hainan Commercial Association South China Microbiology Research Fund
- High Level Hospital-Summit Program
- Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases
- Ministry of Education of China
- European Union's Horizon 2020 (653316)
This publication has 48 references indexed in Scilit:
- Suppression of Zika Virus Infection and Replication in Endothelial Cells and Astrocytes by PKA Inhibitor PKI 14-22Journal of Virology, 2018
- Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypesJournal of Antimicrobial Chemotherapy, 2017
- AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78Antiviral Research, 2017
- The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of CryptococcosisAntimicrobial Agents and Chemotherapy, 2016
- Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirsEmerging Microbes & Infections, 2016
- Ebola and Marburg Hemorrhagic Fevers: Neglected Tropical Diseases?PLOS Neglected Tropical Diseases, 2012
- Hendra and Nipah viruses: why are they so deadly?Current Opinion in Virology, 2012
- Participation of the phosphatidylinositol 3-kinase/Akt pathway in Junín virus replication in vitroVirus Research, 2009
- Zika Virus Outbreak on Yap Island, Federated States of MicronesiaNew England Journal of Medicine, 2009
- Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cellsEuropean Journal of Cancer, 2009